1
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Condition(s):Juvenile Idiopathic ArthritisLast Updated:December 23, 2015Completed
Ibuprofen and Famotidine: 6 Clinical Trials
Hide Studies Not Open or Pending
2
Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)
Condition(s):Osteoarthritis; Rheumatoid Arthritis; Chronic Low Back Pain; Chronic Regional Pain Syndrome; Chronic Soft Tissue PainLast Updated:April 30, 2013Completed
3
Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment
Condition(s):UlcerLast Updated:April 29, 2013Completed
4
Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers
Condition(s):Peptic UlcerLast Updated:April 29, 2013Completed
5
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
Condition(s):Osteoarthritis; Rheumatoid Arthritis; Chronic Low Back Pain; Chronic Regional Pain Syndrome; Chronic Soft Tissue PainLast Updated:July 25, 2013Completed
6
Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)
Condition(s):Glycogen Storage Disease Type IIILast Updated:May 27, 2022Recruiting